Berberine Fails to Deliver on Weight Loss Claims, Study Finds

The popular 'natural' supplement shows no significant impact on visceral or liver fat, raising questions about the supplement industry's lack of regulation.

Feb. 1, 2026 at 11:55am

Got story updates? Submit your updates here. ›

A recent clinical trial has cast doubt on the weight loss benefits of the popular supplement berberine, which had gained massive traction on social media platforms like TikTok. The study, published in JAMA Network Open, found no discernible difference in fat levels between those taking berberine and those receiving a placebo. This news highlights the critical importance of rigorous scientific testing for supplements, which are not subject to the same stringent regulations as pharmaceuticals.

Why it matters

The berberine story is a microcosm of a larger problem within the supplement industry, where products with unsubstantiated claims can proliferate, leaving consumers vulnerable to ineffective and potentially harmful treatments. This failure underscores the need for a more nuanced and scientifically grounded approach to weight loss, moving beyond quick fixes and focusing on personalized nutrition, precision medicine, and lifestyle integration.

The details

The appeal of berberine stemmed from its potential benefits beyond weight loss, including anti-inflammatory properties, cholesterol management, and even potential anti-cancer effects. Its lower price point compared to prescription GLP-1 drugs like Ozempic and Wegovy further fueled its popularity. However, the recent study, involving over 330 participants, found no significant difference in fat levels between those taking berberine and those receiving a placebo.

  • The study was published on February 1, 2026.

The players

Jenna Werner

A registered dietitian who pointed out that individuals promoting berberine often fail to disclose other lifestyle changes contributing to their weight loss, creating a misleading narrative.

Council for Responsible Nutrition

A 2023 report by the Council estimated the supplement industry to be worth over $58 billion, a figure that's projected to continue growing, driven more by clever marketing than by efficacy.

Habit

A company pioneering the field of personalized nutrition, moving beyond one-size-fits-all diets to tailor nutritional plans based on individual genetics, microbiome composition, and metabolic profiles.

Nutrigenomix

A company pioneering the field of personalized nutrition, moving beyond one-size-fits-all diets to tailor nutritional plans based on individual genetics, microbiome composition, and metabolic profiles.

Pear Therapeutics

A company offering a prescription digital therapeutic for substance use disorder, demonstrating the potential of digital therapeutics to manage medical conditions.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident

What’s next

The future of weight loss is likely to focus on personalized nutrition, precision medicine, and the integration of lifestyle factors, with a greater emphasis on rigorous clinical trials and the rise of digital therapeutics.

The takeaway

The failure of berberine to deliver on its weight loss promises underscores the need for a more nuanced and scientifically grounded approach to health and wellness. Consumers should be wary of quick fixes and unsubstantiated claims, and instead focus on evidence-based strategies that prioritize long-term, sustainable well-being.